


























![]()
Q1: 2026-05-06 Earnings Summary
EPS of -$0.99 misses by $0.18
|
Revenue of
$696.00K
(-97.15% Y/Y)
beats by $343.17K
EyePoint, Inc. (EYPT) Q1 2026 Earnings Call May 6, 2026 8:30 AM EDT
Company Participants
George Elston - Executive VP & CFO
Jay Duker - President, CEO & Director
Ramiro Ribeiro - Chief Medical Officer
Michael Campbell - Chief Commercial Officer
Conference Call Participants
Tessa Romero - JPMorgan Chase & Co, Research Division
Yigal Nochomovitz - Citigroup Inc., Research Division
Faisal Khurshid - Jefferies LLC, Research Division
Eddie Hickman - Guggenheim Securities, LLC, Research Division
Debanjana Chatterjee - JonesTrading Institutional Services, LLC, Research Division
Lisa Walter - RBC Capital Markets, Research Division
Nick Quartapella - Robert W. Baird & Co. Incorporated, Research Division
Yale Jen - Laidlaw & Company (UK) Ltd., Research Division
Samuel Rollenhagen - TD Cowen, Research Division
Presentation
Operator
Good morning. My name is Brittany, and I'll be your conference operator today. At this time, I would like to welcome everyone to the EyePoint First Quarter 2026 Financial Results and Recent Corporate Development Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to George Elston, Executive Vice President and Chief Financial Officer of EyePoint.
George Elston
Executive VP & CFO
Thank you, and thank you all for joining us on today's conference call to discuss EyePoint's first quarter 2026 financial results and recent corporate developments. With me today is Dr. Jay Duker, President and Chief Executive Officer of EyePoint. Jay will begin with a review of recent corporate updates and discuss our ongoing clinical programs for DURAVYU in wet AMD and DME. I will close with commentary on the first quarter 2026 financial results. We will then open the call for your questions, where we will be joined by Dr. Ramiro Ribeiro, our Chief Medical Officer; and Mike Campbell, our Chief Commercial Officer.
Earlier this morning, we issued a press
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。